Hawaii Attorney General Lopez wen join hands wit one multistate coalition fo’ throw down da gauntlet to da decision made by one judge insai da U.S. District Court, Texas. Dis decision goin’ make choke hard fo’ get medication abortion access all ova da nation. ?️?
Da amicus brief, wen file insai da U.S. Court of Appeals fo’ da Fifth Circuit, tell da court fo’ hol’ up da district court’s ruling. If dis ruling goin’ get chance fo’ happen, den da ova twenty-year-old U.S. Food and Drug Administration approval of da abortion drug mifepristone goin’ pau. ?⚖️
Lopez an’ da coalition of 24 attorneys general like warn dat if da federal approval fo’ mifepristone goin’ take back, den plenny access fo’ safe abortion care an’ miscarriage management goin’ come less fo’ millions of peeps all ova da country. Goin’ make lives danger an’ stomp on da states’ power fo’ protect an’ make mo’ access to abortion. ??
“Mifepristone stay proven fo’ be safe an’ work,” Lopez wen say in one statement. “Da Texas district court’s decision stay one beeg attack on abortion access, an’ make choke hard fo’ da health, safety, an’ well-being of millions of peeps all ova da country. Even tho’ get dis decision, abortion stay legal an’ can in Hawaii, an’ I goin’ fight fo’ make shua access to dis kine important reproductive health care stay.” ✊?
Dis ruling come from one challenge wen start by anti-abortion groups dat like make da FDA’s approval of mifepristone no moa. ??
On April 7, Judge Matthew Kacsmaryk of da U.S. District Court fo’ da Northern District of Texas, wen tell da FDA fo’ hol’ up da approval of mifepristone, dat wen happen in 2000. Da court’s order no goin’ happen right now, cuz da district court wen wait seven days fo’ give da federal government an’ da drug manufacturer chance fo’ appeal. ⏳?
Lopez an’ da coalition like fo’ da appeals court fo’ keep hol’ up da lower court’s neva seen befo’ an’ wrong kine decision, till da appeal stay pau, cuz get choke clinical research an’ studies dat wen show mifepristone stay safe an’ important fo’ medication abortion in reproductive health care. Dis stay mo’ true fo’ da low-income, no mo’ enough, an’ country kine communities. ??
Right now, da guess stay dat medication abortion make up ’bout 54% of all da abortions wen do in da United States. ???
Da odda attorneys general dat like challenge da ruling stay from Arizona, California, Colorado, Connecticut, Delaware, Illinois, Maine, Maryland, Massachusetts, Michigan, Minnesota, Nevada, New Jersey, New Mexico, New York, North Carolina, Oregon, Pennsylvania, Rhode Island, Vermont, Washington, Wisconsin an’ da District of Columbia. ??⚖️
NOW IN ENGLISH
?? Hawaii AG Joins Forces with Other States to Challenge Abortion Drug Ruling ?♂️?
Hawaii Attorney General Lopez joined a multistate coalition on Monday to challenge the decision issued by a judge in the U.S. District Court in Texas, which could restrict medication abortion access nationwide. ?️?
The amicus brief, filed in the U.S. Court of Appeals for the Fifth Circuit, urges the court to stay the district court’s ruling. If this ruling is allowed to take effect, it could halt the more than two-decades-old U.S. Food and Drug Administration approval of the abortion drug mifepristone. ?⚖️
Lopez and the coalition of 24 attorneys general warn that revoking federal approval for mifepristone will drastically reduce access to safe abortion care and miscarriage management for millions of people across the country, endangering lives and trampling states’ authority to protect and promote access to abortion. ??
“Mifepristone has been proven to be safe and effective,” Lopez said in a statement. “The Texas district court’s decision is an egregious attack on abortion access, and jeopardizes the health, safety, and well-being of millions of people across the country. Despite this decision, abortion remains legal and accessible in Hawaii, and I will continue to fight to maintain access to essential reproductive health care.” ✊?
This ruling comes in a challenge brought by anti-abortion groups seeking to revoke the FDA’s approval of mifepristone. ??
On April 7, Judge Matthew Kacsmaryk of the U.S. District Court for the Northern District of Texas ordered the FDA to stay its approval of mifepristone, which happened in 2000. The court’s order does not take effect immediately, as the district court put its ruling on hold for seven days to give the federal government and the drug manufacturer an opportunity to appeal. ⏳?
Lopez and the coalition are urging the appeals court to continue to stay the lower court’s unprecedented and legally erroneous decision pending the appeal, given the decades of clinical research and studies that have confirmed mifepristone’s safety and the critical role medication abortion plays in reproductive health care, particularly in low-income, underserved, and rural communities. ??
According to current estimates, medication abortion accounts for approximately 54% of all abortions performed in the United States. ???
The other attorneys general challenging the ruling are from Arizona, California, Colorado, Connecticut, Delaware, Illinois, Maine, Maryland, Massachusetts, Michigan, Minnesota, Nevada, New Jersey, New Mexico, New York, North Carolina, Oregon, Pennsylvania, Rhode Island, Vermont, Washington, Wisconsin, and the District of Columbia. ??⚖️
